Cargando…
Surfactantsubstitutionstherapie: Ein entscheidender Durchbruch in der Behandlung des Atemnotsyndroms Frühgeborener
Surfactant replacement therapy is a major breakthrough in neonatal medicine. Prophylaxis or treatment of neonatal respiratory distress syndrome (RDS) with various surfactant preparations is now a clinical reality. With either strategy the incidence of air leaks and mortality is reduced; more babies...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095786/ https://www.ncbi.nlm.nih.gov/pubmed/32226146 http://dx.doi.org/10.1007/s00112-002-0434-y |